REGN vs TKNO · P/E 14, rev $14.34B vs rev $37.7M
Regeneron Pharmaceuticals Inc (REGN) versus Alpha Teknova Inc (TKNO) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Alpha Teknova Inc (TKNO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TKNO revenue for 2024-12-31 was $37.7M. Net income was -$26.7M. Revenue was up 2.9% from 2023-12-31 to 2024-12-31. TKNO currently screens at market cap $221.4M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TKNO currently screens at market cap $221.4M.
Not investment advice. Open the REGN and TKNO stock pages for the full models.
Not investment advice.